{"id":"https://openalex.org/W4392680345","doi":"https://doi.org/10.1158/0008-5472.c.6508800","title":"Data from FGF2 from Marrow Microenvironment Promotes Resistance to FLT3 Inhibitors in Acute Myeloid Leukemia","display_name":"Data from FGF2 from Marrow Microenvironment Promotes Resistance to FLT3 Inhibitors in Acute Myeloid Leukemia","publication_year":2023,"publication_date":"2023-03-31","ids":{"openalex":"https://openalex.org/W4392680345","doi":"https://doi.org/10.1158/0008-5472.c.6508800"},"language":"en","primary_location":{"id":"doi:10.1158/0008-5472.c.6508800","doi":"https://doi.org/10.1158/0008-5472.c.6508800","is_oa":true,"landing_page_url":"https://doi.org/10.1158/0008-5472.c.6508800","pdf_url":null,"source":null,"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":"acceptedVersion","is_accepted":true,"is_published":false,"raw_source_name":"American Association for Cancer Research","raw_type":"posted-content"},"volume":null,"type":"other","indexed_in":["crossref"],"open_access":{"is_oa":true,"oa_status":"gold","oa_url":"https://doi.org/10.1158/0008-5472.c.6508800","any_repository_has_fulltext":null},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5005105433","display_name":"Elie A. Traer","orcid":"https://orcid.org/0000-0001-8844-2345","observed_orcids":["https://orcid.org/0000-0001-8844-2345"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Elie Traer","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5042108911","display_name":"Jacqueline Martinez","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Jacqueline Martinez","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5052380534","display_name":"Nathalie Javidi\u2010Sharifi","orcid":"https://orcid.org/0000-0003-0702-9837","observed_orcids":["https://orcid.org/0000-0003-0702-9837"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Nathalie Javidi-Sharifi","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5076074507","display_name":"Anupriya Agarwal","orcid":"https://orcid.org/0000-0002-8319-6162","observed_orcids":["https://orcid.org/0000-0002-8319-6162"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Anupriya Agarwal","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5102954255","display_name":"Jennifer B. Dunlap","orcid":"https://orcid.org/0000-0002-6399-6592","observed_orcids":["https://orcid.org/0000-0002-6399-6592"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Jennifer Dunlap","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5067240272","display_name":"Isabel A. English","orcid":"https://orcid.org/0000-0002-0566-9585","observed_orcids":["https://orcid.org/0000-0002-0566-9585"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Isabel English","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5110302760","display_name":"Tibor J. Kovacsovics","orcid":"https://orcid.org/0000-0003-3294-0761","observed_orcids":["https://orcid.org/0000-0003-3294-0761"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Tibor Kovacsovics","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5134831711","display_name":"Jeffrey W Tyner","orcid":"https://orcid.org/0000-0002-2133-0960","observed_orcids":["https://orcid.org/0000-0002-2133-0960"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Jeffrey W. Tyner","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5055242592","display_name":"Melissa Hirose Wong","orcid":"https://orcid.org/0000-0002-5127-279X","observed_orcids":["https://orcid.org/0000-0002-5127-279X"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Melissa Wong","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"last","author":{"id":"https://openalex.org/A5125591963","display_name":"Brian J. Druker","orcid":"https://orcid.org/0000-0001-8331-8206","observed_orcids":["https://orcid.org/0000-0001-8331-8206"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Brian J. Druker","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]}],"institutions":[],"countries_distinct_count":0,"institutions_distinct_count":0,"corresponding_author_ids":[],"corresponding_institution_ids":[],"apc_list":null,"apc_paid":null,"fwci":null,"has_fulltext":false,"cited_by_count":0,"citation_normalized_percentile":null,"cited_by_percentile_year":null,"biblio":{"volume":null,"issue":null,"first_page":null,"last_page":null},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10309","display_name":"Acute Myeloid Leukemia Research","score":1.0,"subfield":{"id":"https://openalex.org/subfields/2720","display_name":"Hematology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T10309","display_name":"Acute Myeloid Leukemia Research","score":1.0,"subfield":{"id":"https://openalex.org/subfields/2720","display_name":"Hematology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T11559","display_name":"Retinoids in leukemia and cellular processes","score":0.0,"subfield":{"id":"https://openalex.org/subfields/1312","display_name":"Molecular Biology"},"field":{"id":"https://openalex.org/fields/13","display_name":"Biochemistry, Genetics and Molecular Biology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T11215","display_name":"Chronic Myeloid Leukemia Treatments","score":0.0,"subfield":{"id":"https://openalex.org/subfields/2720","display_name":"Hematology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/fgf2","display_name":"FGF2","score":0.8270000219345093},{"id":"https://openalex.org/keywords/flt3-inhibitors","display_name":"FLT3 inhibitors","score":0.8169999718666077},{"id":"https://openalex.org/keywords/quizartinib","display_name":"quizartinib","score":0.9279999732971191},{"id":"https://openalex.org/keywords/acute-myeloid-leukemia","display_name":"acute myeloid leukemia","score":0.9679999947547913},{"id":"https://openalex.org/keywords/flt3-itd-mutation","display_name":"FLT3-ITD","score":0.9520000219345093},{"id":"https://openalex.org/keywords/drug-resistance","display_name":"drug resistance","score":0.8799999952316284},{"id":"https://openalex.org/keywords/bone-marrow-microenvironment","display_name":"bone marrow microenvironment","score":0.9620000123977661},{"id":"https://openalex.org/keywords/flt3-ligand","display_name":"Flt3 ligand","score":0.902999997138977},{"id":"https://openalex.org/keywords/fgfr1","display_name":"FGFR1","score":0.9559999704360962},{"id":"https://openalex.org/keywords/ras-mapk-pathway","display_name":"RAS/MAPK pathway","score":0.9200000166893005},{"id":"https://openalex.org/keywords/mesenchymal-stem-cells","display_name":"mesenchymal stem cells","score":0.8610000014305115},{"id":"https://openalex.org/keywords/combination-therapy","display_name":"combination therapy","score":0.7990000247955322}],"concepts":[{"id":"https://openalex.org/C2778729363","wikidata":"https://www.wikidata.org/wiki/Q11688946","display_name":"Myeloid leukemia","level":2,"score":0.8381582498550415},{"id":"https://openalex.org/C2778461978","wikidata":"https://www.wikidata.org/wiki/Q29496","display_name":"Leukemia","level":2,"score":0.5327708125114441},{"id":"https://openalex.org/C502942594","wikidata":"https://www.wikidata.org/wiki/Q3421914","display_name":"Cancer research","level":1,"score":0.5108751654624939},{"id":"https://openalex.org/C2779282312","wikidata":"https://www.wikidata.org/wiki/Q1956561","display_name":"Myeloid","level":2,"score":0.4585352838039398},{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.4363691806793213},{"id":"https://openalex.org/C2994430510","wikidata":"https://www.wikidata.org/wiki/Q3270846","display_name":"Myeloid cells","level":3,"score":0.42416274547576904},{"id":"https://openalex.org/C203014093","wikidata":"https://www.wikidata.org/wiki/Q101929","display_name":"Immunology","level":1,"score":0.2793912887573242}],"mesh":[],"locations_count":1,"locations":[{"id":"doi:10.1158/0008-5472.c.6508800","doi":"https://doi.org/10.1158/0008-5472.c.6508800","is_oa":true,"landing_page_url":"https://doi.org/10.1158/0008-5472.c.6508800","pdf_url":null,"source":null,"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":"acceptedVersion","is_accepted":true,"is_published":false,"raw_source_name":"American Association for Cancer Research","raw_type":"posted-content"}],"best_oa_location":{"id":"doi:10.1158/0008-5472.c.6508800","doi":"https://doi.org/10.1158/0008-5472.c.6508800","is_oa":true,"landing_page_url":"https://doi.org/10.1158/0008-5472.c.6508800","pdf_url":null,"source":null,"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":"acceptedVersion","is_accepted":true,"is_published":false,"raw_source_name":"American Association for Cancer Research","raw_type":"posted-content"},"sustainable_development_goals":[{"id":"https://metadata.un.org/sdg/3","score":0.9789000153541565,"display_name":"Good health and well-being"}],"study_designs":[],"awards":[],"funders":[],"has_content":{"grobid_xml":false,"pdf":false},"content_urls":null,"referenced_works_count":0,"referenced_works":[],"related_works":["https://openalex.org/W2526397866","https://openalex.org/W2564458993","https://openalex.org/W2725940016","https://openalex.org/W2528334185","https://openalex.org/W3095865064","https://openalex.org/W2764314945","https://openalex.org/W4255571618","https://openalex.org/W2232309930","https://openalex.org/W4393089069","https://openalex.org/W2330409204"],"abstract_inverted_index":{"Abstract":[0],"Potent":[1],"FLT3":[2,18,48,129],"inhibitors,":[3],"such":[4],"as":[5],"quizartinib":[6],"(AC220),":[7],"have":[8],"shown":[9],"promise":[10],"in":[11,143,179,188],"treating":[12],"acute":[13],"myeloid":[14],"leukemia":[15],"(AML)":[16],"containing":[17],"internal":[19],"tandem":[20],"duplication":[21],"(ITD)":[22],"mutations.":[23,158],"However,":[24],"responses":[25],"are":[26],"not":[27],"durable":[28],"and":[29,51,91,105,130,154],"resistance":[30,43,70,86,125,157],"develops":[31],"within":[32],"months.":[33],"In":[34],"this":[35],"study,":[36],"we":[37],"outline":[38],"a":[39,163],"two-step":[40],"model":[41],"of":[42,68,77,89,103,123,128,156,165,186],"whereby":[44],"extrinsic":[45],"microenvironmental":[46],"proteins":[47],"ligand":[49],"(FL)":[50],"fibroblast":[52],"growth":[53],"factor":[54],"2":[55],"(FGF2)":[56],"protect":[57],"FLT3-ITD+":[58],"MOLM14":[59],"cells":[60,97],"from":[61,111,174],"AC220,":[62,119],"providing":[63],"time":[64],"for":[65],"subsequent":[66],"accumulation":[67],"ligand-independent":[69],"mechanisms.":[71],"FL":[72,108],"directly":[73],"attenuated":[74],"AC220":[75,138],"inhibition":[76,102],"FLT3,":[78],"consistent":[79],"with":[80,137],"previous":[81],"reports.":[82],"Conversely,":[83],"FGF2":[84,110,141],"promoted":[85],"through":[87],"activation":[88],"FGFR1":[90,104],"downstream":[92],"MAPK":[93],"effectors;":[94],"these":[95,160],"resistant":[96,113],"responded":[98],"synergistically":[99],"to":[100,118,150,169,182],"combinatorial":[101],"FLT3.":[106],"Removing":[107],"or":[109],"ligand-dependent":[112],"cultures":[114],"transiently":[115],"restored":[116],"sensitivity":[117],"but":[120],"accelerated":[121],"acquisition":[122],"secondary":[124],"via":[126],"reactivation":[127],"RAS/MAPK":[131],"signaling.":[132],"FLT3-ITD":[133,189],"AML":[134],"patients":[135],"treated":[136],"developed":[139],"increased":[140],"expression":[142],"marrow":[144,177],"stromal":[145],"cells,":[146],"which":[147],"peaked":[148],"prior":[149],"overt":[151],"clinical":[152],"relapse":[153],"detection":[155],"Overall,":[159],"results":[161],"support":[162],"strategy":[164],"early":[166,171],"combination":[167],"therapy":[168],"target":[170],"survival":[172],"signals":[173],"the":[175,184],"bone":[176],"microenvironment,":[178],"particular":[180],"FGF2,":[181],"improve":[183],"depth":[185],"response":[187],"AML.":[190],"Cancer":[191],"Res;":[192],"76(22);":[193],"6471\u201382.":[194],"\u00a92016":[195],"AACR.":[196]},"counts_by_year":[],"updated_date":"2026-10-16T09:59:22.235173","created_date":"2024-03-13T00:00:00"}